{"id":"W2899995714","doi":"10.1093/neuonc/noy148.039","title":"ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Chemoradiotherapy; Hazard ratio; Regimen; Population; Glioma; Clinical endpoint; Radiation therapy; Phases of clinical research; Chemotherapy; Confidence interval; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003454523,0.001390232,0.001500464,0.0004627211,0.0003627569,0.0008839504,0.0009927239,0.0009722919,0.002117147],"category_scores_gemma":[0.001427923,0.0004471875,0.001160941,0.0003941405,0.0008625704,0.0005437026,0.0002988124,0.002409355,0.0009720752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008772564,"about_ca_system_score_gemma":0.001415913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069379,"about_ca_topic_score_gemma":0.002442483,"domain_scores_codex":[0.9990645,0.0006143794,0.00003678789,0.0001018651,0.00008431792,0.00009815746],"domain_scores_gemma":[0.9987556,0.0001614275,0.0003338561,0.00015975,0.00009028339,0.0004992065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6024515,0.1424731,0.03122914,0.0006584503,0.002828034,0.0004125887,0.000340678,0.003925368,0.08065958,0.0002044731,0.007993814,0.1268232],"study_design_scores_gemma":[0.215789,0.7255821,0.04149308,0.0000389627,0.001105906,0.0005396646,0.00006770795,0.001527395,0.009533222,0.0001528635,0.004127558,0.00004253124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959085,0.001072036,0.0003988906,0.0001952,0.00006567584,0.0008097253,0.0008610797,0.00005447975,0.0006344751],"genre_scores_gemma":[0.9863297,0.00111221,0.00200273,0.0008124472,0.0001817376,0.001796543,0.004791217,0.00006117558,0.002912146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003454523,"threshold_uncertainty_score":0.01826948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03064476972421659,"score_gpt":0.3551973150370242,"score_spread":0.3245525453128076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}